1. Introduction {#sec1-molecules-24-01115}
===============

There is considerable interest in finding new molecular systems that could be a basis for the design of novel therapeutic drugs. For the accomplishment of this objective, researchers have carried out searches for these potential therapeutic molecules in nature, based on experience acquired in recent decades. The sea is one of those places in which searches are carried out, as it is inhabited by an enormous variety of animal, plant, and microbial life, which generates diverse molecules and remains relatively unexplored.

Among the chemical species that can be found in marine life, peptides are one of the most important chemical groups. Peptides are molecules formed by the combination of natural amino acids and some of their variants, and represent ideal chemical species for the design of therapeutic drugs, since they possess interesting properties inherent to the molecular systems, ranging from small amino acids to large proteins, with which they are often compared.

Soblidotin, also known as Auristatin PE, has been investigated due its potential anti-tumor effects \[[@B1-molecules-24-01115]\] and is a good example of a sea-derived peptide. According to the National Cancer Institute (NCI) Thesaurus, Tasidotin is a third-generation, synthetic, water-soluble, pentapeptide analog of the marine depsipeptide Dolastatin 15, with potential anti-mitotic and anti-neoplastic activities.

When one is working with Computational Chemistry and Molecular Modeling, there is not a universal methodology that could be applied to the entire spectra of known or unknown molecular systems. As such, our own devised methodology cannot be considered useful for all systems. The workaround that researchers in this field have found relies on studying, with a particular methodology, different but related families of molecules, in order to see if the proposed methodology can be applied with the same degree of success to the different group of molecules, and that the results obtained with a particular family of molecules are good not just by chance or some kind of serendipity. Indeed, the larger the number of studies with different groups of molecules, the greater the validity of the used methodologies.

Thus, the objective of this work is to perform a comparative study of the chemical reactivity of the Soblidotin and Tasidotin peptides, of marine origin, by resorting to Chemical Reactivity Theory (CRT) \[[@B2-molecules-24-01115]\], in addition to an investigation of their potential AGEs inhibition abilities, following a protocol devised by our group \[[@B3-molecules-24-01115],[@B4-molecules-24-01115],[@B5-molecules-24-01115],[@B6-molecules-24-01115],[@B7-molecules-24-01115],[@B8-molecules-24-01115],[@B9-molecules-24-01115],[@B10-molecules-24-01115],[@B11-molecules-24-01115],[@B12-molecules-24-01115]\]. Moreover, the bioactivity scores for Soblidotin and Tasidotin are predicted through an empirical procedure, based on comparison with molecular structures with well-known pharmacological properties.

2. Computational Methodology {#sec2-molecules-24-01115}
============================

Rather than resorting to the usual methodologies in Medicinal Chemistry, related to Molecular Docking, QSAR, and QSPR, we prefer to study the potential usefulness of the peptides by considering Computational Chemistry and Molecular Modelling, based on CRT and some semiempirical relationships relying on collected databases.

As with our recent studies \[[@B3-molecules-24-01115],[@B4-molecules-24-01115],[@B5-molecules-24-01115],[@B6-molecules-24-01115],[@B7-molecules-24-01115],[@B8-molecules-24-01115],[@B9-molecules-24-01115],[@B10-molecules-24-01115]\], the computational tasks in this work have been done by considering the popular Gaussian 09 software \[[@B13-molecules-24-01115]\]. Following the conclusions obtained from those studies, the MN12SX density functional \[[@B14-molecules-24-01115]\] is chosen, because it can be considered to be well-behaved; according to our proposed, above-mentioned criteria. Accordingly, the calculation of the electronic properties used a model chemistry, based on the mentioned density functional in connection with the Def2TZVP basis set, while a smaller Def2SVP was considered for the prediction of the most stable structures \[[@B15-molecules-24-01115],[@B16-molecules-24-01115]\]. In order to obtain accurate results, all calculations were performed using water as the solvent, simulated with the SMD model \[[@B17-molecules-24-01115]\].

3. Results and Discussion {#sec3-molecules-24-01115}
=========================

The molecular structures of the Soblidotin and Tasidotin peptides, which are depicted in [Figure 1](#molecules-24-01115-f001){ref-type="fig"}, were optimized in absence of solvent by resorting to the semiempirical DFTBA model (available in Gaussian 09), starting from the five most stable conformers selected from a pre-optimization accomplished by means of Molecular Mechanics techniques \[[@B18-molecules-24-01115],[@B19-molecules-24-01115],[@B20-molecules-24-01115],[@B21-molecules-24-01115],[@B22-molecules-24-01115]\]. The resulting conformers were processed, as is customary within Computational Chemistry, to obtain the desired calculated properties, according to the techniques mentioned in the previous section.

The calculation of the maximum wavelength absorption of the Soblidotin and Tasidotin peptides was performed by conducting ground-state determinations with the same model chemistry. These results, together with the total, HOMO, and LUMO electronic energies, as well as the HOMO--LUMO gap, are shown in [Table 1](#molecules-24-01115-t001){ref-type="table"}.

To get a glimpse of the electronic distribution around the atoms of both molecules, graphical sketches of the total electronic densities for Soblidotin and Tasidotin are presented in [Figure 2](#molecules-24-01115-f002){ref-type="fig"}.

3.1. Calculation of Global Reactivity Descriptors {#sec3dot1-molecules-24-01115}
-------------------------------------------------

The definitions for the chemical reactivity descriptors, coming from CRT, are provided in terms of the energies of the HOMO and LUMO, $\epsilon_{H}$ and $\epsilon_{L}$, respectively, as: The electronegativity $\chi \approx \frac{1}{2}\left( \epsilon_{L} + \epsilon_{H} \right)$ \[[@B23-molecules-24-01115],[@B24-molecules-24-01115]\], the global hardness $\eta \approx \left( \epsilon_{L} - \epsilon_{H} \right)$ \[[@B23-molecules-24-01115],[@B24-molecules-24-01115]\], the electrophilicity $\omega\mspace{600mu} = \mspace{600mu} \approx \mspace{600mu}\left( \epsilon_{L} + \epsilon_{H} \right)^{2}/{4\left( \epsilon_{L} - \epsilon_{H} \right)}$ \[[@B25-molecules-24-01115]\], the electrodonating power $\omega^{-} \approx \left( 3\epsilon_{H} + \epsilon_{L} \right)^{2}/{16\eta}$ \[[@B26-molecules-24-01115]\], the electroaccepting power $\omega^{+} \approx \left( \epsilon_{H} + 3\epsilon_{L} \right)^{2}/{16\eta}$ \[[@B26-molecules-24-01115]\], and the net electrophilicity $\Delta\omega^{\pm}\mspace{600mu} = \mspace{600mu}\omega^{+}\mspace{600mu} + \mspace{600mu}\omega^{-}$ \[[@B27-molecules-24-01115]\]. The results of their calculations for the Soblidotin and Tasidotin peptides are presented in [Table 2](#molecules-24-01115-t002){ref-type="table"}.

We can see, from [Table 2](#molecules-24-01115-t002){ref-type="table"}, that, for both peptides, their electronating ability is more important that their electroaccepting ability, although there was not a significant difference between the values of the global reactivity descriptors of each of them.

3.2. Determination of the Local Reactivity Descriptors {#sec3dot2-molecules-24-01115}
------------------------------------------------------

If we now focus on the local reactivity descriptors coming from CRT, then the definitions will be: $f^{+}\left( \mathbf{r} \right) = \rho_{N + 1}\left( \mathbf{r} \right) - \rho_{N}\left( \mathbf{r} \right)$ for the Nucleophilic Fukui Function \[[@B23-molecules-24-01115],[@B24-molecules-24-01115]\], $f^{-}\left( \mathbf{r} \right) = \rho_{N}\left( \mathbf{r} \right) - \rho_{N - 1}\left( \mathbf{r} \right)$ for the Electrophilic Fukui Function \[[@B23-molecules-24-01115],[@B24-molecules-24-01115]\], and $\Delta f\left( \mathbf{r} \right)$ = $\left( {{\partial\, f\left( \mathbf{r} \right)}/{\partial\, N}} \right)_{\upsilon(\mathbf{r})}$ for the Dual Descriptor \[[@B2-molecules-24-01115],[@B28-molecules-24-01115],[@B29-molecules-24-01115],[@B30-molecules-24-01115],[@B31-molecules-24-01115],[@B32-molecules-24-01115]\], considering the electronic densities for a system with $N + 1$, *N*, and $N - 1$ electrons, respectively.

The Electrophilic Fukui functions $f^{-}\left( \mathbf{r} \right)$ and Nucleophilic Fukui functions $f^{+}\left( \mathbf{r} \right)$ for the anticancer marine peptides Soblidotin and Tasidotin are shown in [Figure 3](#molecules-24-01115-f003){ref-type="fig"}.

3.3. Calculation of the pKas of the Antimicrobial Peptides of Marine Origin and Quantification of the AGEs Inhibitor Ability {#sec3dot3-molecules-24-01115}
----------------------------------------------------------------------------------------------------------------------------

For the consideration of natural products to be useful for applications in Medicinal Chemistry, the knowledge of their pKas is very important. For large molecules, such as the peptides studied in this work, the experimental determination of their pKa is sometimes difficult. However, we have already shown that the pKa of a peptide can be predicted by applying a relationship with the global hardness $\eta$ \[[@B11-molecules-24-01115]\]. Thus, the values of the pKas of Soblidotin and Tasidotin, determined through that relationship, are presented in [Table 3](#molecules-24-01115-t003){ref-type="table"}:

It is our belief that these results could be of interest for processes, involving drug design and development, using these peptides.

The Maillard reaction is, in fact, a collection of chained chemical reactions that start from the interaction between a reducing carbonyl and the free amino group of a peptide or protein. This chain of reactions leads to a final group of molecules, known as Advanced Glycation Endproducts (or AGEs), which are considered to be the main reasons for the development of some diseases, such as Diabetes, Alzheimers, and Parkinsons \[[@B33-molecules-24-01115]\].

Many compounds have been devised as drugs with the goal of inhibiting the formation of AGEs, which include Pyridoxamine, Aminoguanidine, Carnosine, Metformin, Pioglitazone, and Tenilsetam \[[@B34-molecules-24-01115],[@B35-molecules-24-01115]\]. Previous results from our group on the glycation process led us to conclude that the nucleophilicity N \[[@B36-molecules-24-01115]\] may be a good descriptor for the AGE inhibition ability, and a nice definition for it could be based on the the inverse of the net electrophilicity $\Delta\omega^{\pm}$.

If we consider that this relationship is valid, then, based on the calculated global descriptors for Soblidotin and Tasidotin, it should be possible to predict their AGE inhibition ability, by comparison with the mentioned drugs:

It can be seen that the studied peptides possess AGE inhibitor abilities, which are lower than that of other molecular systems already on the market \[[@B34-molecules-24-01115],[@B35-molecules-24-01115]\].

3.4. Bioactivity Scores {#sec3dot4-molecules-24-01115}
-----------------------

When looking for the potential therapeutic capacities of new molecules, an interesting approach is an empirical procedure based on comparison with the properties of molecular structures with well-known pharmacological properties. These values are known as Bioactivity Scores, and can be easily estimated by resorting to the free online Molinspiration software, as shown in [Table 4](#molecules-24-01115-t004){ref-type="table"}.

The results from [Table 4](#molecules-24-01115-t004){ref-type="table"} can be interpreted by considering the factors for evaluation of the Bioactivity Scores, which are shown in [Table 5](#molecules-24-01115-t005){ref-type="table"}.

4. Conclusions {#sec4-molecules-24-01115}
==============

The outcomes of this work have resulted in the determination of important information about the chemical reactivity of two peptides of marine origin with potential therapeutic properties as anticancer drugs, Soblidotin and Tasidotin. This has been done by resorting to Chemical Reactivity Theory and some empirical relationships for the prediction of the pKa values, for their AGE inhibition abilities, and for the prediction of their Bioactivity Scores (as a measure of bioactivity).

The total electronic densities for both peptides have been displayed in the form of graphical sketches, as well as the HOMO and LUMO orbitals, as an approximation to the electrophilic and nucleophilic Fukui functions.

All these computed values could be of interest in the design and development of new pharmaceutical drugs, as well as for the practice of Medicinal Chemistry.
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molecules-24-01115-t001_Table 1

###### 

Electronic energies of the neutral molecular systems (in au) of the anticancer marine peptides, Soblidotin and Tasidotin; the HOMO and LUMO orbital energies, as well as the HOMO--LUMO gap (in eV), and the maximum absorption wavelengths $\lambda_{max}$ (in nm).

  Molecule     Total Electronic Energy   HOMO      LUMO      HOMO--LUMO Gap   $\mathbf{\mathbf{\lambda}_{\mathbf{\max}}}$
  ------------ ------------------------- --------- --------- ---------------- ---------------------------------------------
  Soblidotin   −2250.5737                −6.3060   −0.7353   5.5707           223
  Tasidotin    −1958.1339                −6.2790   −0.6490   5.6300           220

molecules-24-01115-t002_Table 2

###### 

Global reactivity descriptors of the anticancer marine peptides Soblidotin and Tasidotin.

  Molecule     Electronegativity       Global Hardness          Electrophilicity
  ------------ ----------------------- ------------------------ ----------------------
  Soblidotin   3.5206                  5.5707                   1.1125
  Tasidotin    3.4640                  5.6300                   1.0657
  Molecule     Electrodonating Power   Electroaccepting Power   Net Electrophilicity
  Soblidotin   4.3334                  0.8128                   5.1463
  tasidotin    4.2152                  0.7512                   4.9964

molecules-24-01115-t003_Table 3

###### 

pKa values for the anticancer marine peptides Soblidotin and Tasidotin.

  Molecule     pKa
  ------------ -------
  Soblidotin   11.70
  Tasidotin    11.65

molecules-24-01115-t004_Table 4

###### 

Empirical Bioactivity Scores of the anticancer marine peptides, Soblidotin and Tasidotin.

  Molecule     GPCR Ligand   Ion Channel Modulator   Kinase Inhibitor   Nuclear Receptor Ligand   Protease Inhibitor   Enzyme Inhibitor
  ------------ ------------- ----------------------- ------------------ ------------------------- -------------------- ------------------
  Soblidotin   −0.30         −1.30                   −1.07              −1.34                     0.19                 −0.83
  Tasidotin    0.19          −0.43                   −0.23              0.36                      0.51                 −0.13

molecules-24-01115-t005_Table 5

###### 

Factors for Evaluation of the Empirical Bioactivity Scores.

  Active   Moderately Active      Inactive
  -------- ---------------------- ----------
  \>0      Between −5.0 and 0.0   \<−5.0

[^1]: These authors contributed equally to this work.
